&w=3840&q=100)
Is that stomach pain pancreatitis? How to know when to see a doctor
If you've been hearing the word 'pancreatitis' more often lately, you're not alone. Hospitals across India are reporting a rise in cases — not just among older adults, but increasingly among people in their 30s and 40s.
According to the Global Burden of Disease Study, cases of pancreatitis are expected to rise globally — from about 2.8 million in 2019 to nearly 4 million by 2044.
What's driving this surge? And more importantly, what can you do to prevent it?
Let's break it down.
What is pancreatitis?
Pancreatitis is the inflammation of the pancreas — a small, powerful organ behind your stomach. The pancreas has two major roles: it maintains blood sugar levels through insulin secretion and supports digestion via enzyme secretion. When the pancreas gets inflamed, digestive enzymes can start attacking the pancreas itself. That's when things get painful — and dangerous.
There are two main types:
Acute pancreatitis: Comes on suddenly, often severe and potentially life-threatening
Chronic pancreatitis: Long-term inflammation that may result in permanent damage
Why is pancreatitis rising in India?
Doctors say it's a mix of changing lifestyles, diet, and delayed medical attention.
Founder & Chairman Emeritus, Dr Batra's Healthcare, Dr Mukesh Batra told Business Standard:
'Owing to the major lifestyle shift and healthcare gaps, pancreatitis cases have seen a surge in India. One of the major determinants is heavy alcohol use, particularly among young adults. Increased intake of fat and low fibre, physical inactivity, delayed diagnosis, and increased obesity are other major determinants. Also, gallstones, a common condition in Indian women, tend to be associated with acute pancreatitis. Increasingly poor eating habits and irregular working hours are also pushing the younger generation towards vulnerability.'
Common triggers include:
Excessive alcohol consumption
Gallstones, especially in women
High triglyceride levels (above 1000 mg/dL)
Smoking, which worsens inflammation
Certain medications, like corticosteroids and diuretics
Genetic predisposition
Abdominal trauma or surgery
'A rare but important form of pancreatitis happens when the immune system mistakenly attacks healthy pancreatic tissue… If you wait too long to get treatment, it can lead to serious problems like damage to the pancreas, infection, diabetes, or even pancreatic cancer,' said Dr Sugi Subramaniam R V, Senior Consultant – Surgical Gastroenterology, SRM Global Hospitals, Chennai.
What are the key warning signs of pancreatitis?
Pancreatitis symptoms can be severe and should never be ignored. Watch out for:
Sudden, intense upper abdominal pain (sometimes radiating to the back)
Nausea and vomiting
Fever and chills
Bloating or a tender belly
Rapid heartbeat
"Chronic cases may also show signs like weight loss, oily stools, and fatigue — often confused with gastritis or stress," added Dr Sugi.
How is pancreatitis diagnosed and treated?
In acute cases, hospitalisation is often required.
Standard diagnostic tools include:
Blood tests for enzyme levels (amylase, lipase)
Ultrasound, CT, or MRI scans
Endoscopic ultrasound (EUS) or MRCP for detailed duct imaging
Stool tests in chronic conditions to assess fat absorption
Treatment includes:
Resting the pancreas (usually through fasting)
IV fluids and pain management
Addressing the root cause (e.g. gallstones, medications)
Can pancreatitis be prevented?
Yes — largely through lifestyle changes. Experts recommend:
Limiting alcohol
Avoiding smoking
Adopting a low-fat, high-fibre diet
Staying hydrated
Managing cholesterol and diabetes
Promptly treating gallstones
Avoiding misuse of medications like steroids
Is there a role for homeopathy?
'Depending on the constitution of the patient and the profile of symptoms, homeopathic remedies such as Iris Versicolor, Chelidonium, or Nux Vomica can be prescribed… The best recovery results lie in early diagnosis, integrative care, and lifestyle correction,' adds Dr Batra.
Bottom line
So the next time you feel severe stomach pain — don't just pop a painkiller and move on. It might be your pancreas waving a red flag.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
2 hours ago
- Time of India
BIRAC in pact with Miltenyi Biotec India to boost India's capabilities in cell & gene therapy
HYDERABAD: In a move aimed at beefing up India's leadership in cutting-edge biotherapeutics such as cell and gene therapy (CGT), the Biotechnology Industry Research Assistance Council (BIRAC) has signed a strategic letter of intent (LOI) with Miltenyi Biotec India Private Limited to boost India's capabilities in CGT through capacity building, advancing clinical research and solving unmet medical needs by local manufacturing of cell therapies. The LOI was signed at the BIO International Convention 2025 that kicked off in Boston this week. Through the partnership, Miltenyi Biotec and BIRAC plan to build national capabilities and upskill scientific talent through structured training and capacity-building programmes for clinicians, researchers, and technicians in CGT manufacturing, analytics, and quality control. The collaboration also aims to expand translational research efforts through co-development of academic and multi-center studies, focusing on next-generation therapies to solve India's unmet medical needs in malignancies, autoimmune diseases and rare diseases. It will also establish point-of-care (PoC) CAR-T centers across India using automated manufacturing platforms such as Miltenyi's CliniMACS Prodigy system to enable cost-effective and scalable access to personalised CGT treatments. The initiative will also promote targeted cell therapy research and support local innovation through the identification and mentoring of Indian startups in line with the 'Make in India' mission by enhancing domestic production of critical and manufacturing components, and supporting the development of national CGT centers of excellence. Commenting on the partnership. Priya Kapoor-Hingorani, managing director, MiltenyiBiotec India, said, 'The potential of India draws us. Our partnership with BIRAC focuses on updating and upskilling scientists to strengthen the country's scientific capabilities and infrastructure. Together, we're exploring how to address current unmet needs in medical science, particularly in areas like autoimmune and rare diseases by enhancing access through innovative mechanisms such as point-of-care CAR-T and graft engineering. ' BIRAC managing director Dr Jitendra Kumar said the LOI was inked with Miltenyi, an MNC that is known for its expertise in CGT, as India is aspiring to become a global leader in this space and to achieve that goal it requires a strong foundation of skilled manpower.
&w=3840&q=100)

Business Standard
4 hours ago
- Business Standard
Abbott, MSD join hands to distribute key diabetic drug across India
Two multinational drug makers—Abbott and MSD Pharmaceuticals—have announced a strategic collaboration to distribute the anti-diabetic medicine sitagliptin and its combinations in India. MSD's sitagliptin and its combinations are marketed in India under the brand names Januvia, Janumet, and Janumet XR. The two American pharmaceutical giants will join hands to leverage Abbott's extensive Indian footprint to distribute this widely used diabetes medication. Sitagliptin, a DPP4 inhibitor used to treat Type 2 diabetes, was launched by MSD in India in 2008. Following the patent expiry in mid-2022, several Indian drugmakers introduced generic versions of the molecule. The sitagliptin market in India is estimated to be worth ₹950–1,000 crore, forming a significant share of the country's ₹20,700 crore diabetes market. MSD said in a statement that its sitagliptin brands continue to be among the leaders in the segment, even after the loss of exclusivity. Before patent expiry, MSD had partnered with Sun Pharmaceutical Industries under a licensing agreement to distribute the drug in India. At that time, there were only four to five sitagliptin brands in the market, including Istavel and Istamet marketed by Sun Pharma. However, post-expiry, the market was flooded with over 150 brands from more than 60 pharmaceutical companies. MSD and Abbott's partnership aims to strengthen the reach of the innovator brands in a competitive market. In India, at least 60 per cent of deaths are attributed to non-communicable diseases (NCDs), with diabetes, cardiovascular conditions, and cancer being the leading causes. The country has an estimated 101 million people with diabetes and 136 million people who are pre-diabetic—at heightened risk of developing the disease in the future. 'As the largest diversified healthcare company in India, Abbott is uniquely positioned to address some of the most pressing health challenges, particularly non-communicable diseases, which contribute to a considerable burden on the healthcare system,' said Ambati Venu, vice-president, Abbott India. He added, 'We offer a wide range of solutions to help people manage diabetes more effectively—including testing, continuous glucose monitoring, nutrition, and a complete diabetes medicines portfolio. Through our extensive presence, we can help people in India better manage their Type 2 diabetes and take control of their health.' Rehan A Khan, managing director, MSD India Region, stated, 'Since its introduction in India over 17 years ago, our sitagliptin portfolio has positively impacted the lives of hundreds of thousands of patients across the country and has earned the trust of both doctors and patients. Our partnership with Abbott establishes a sustainable business model that will enable us to continue serving patients throughout India with these diabetes treatments.'


NDTV
5 hours ago
- NDTV
International Yoga Day 2025: Best Yoga Poses That Target Belly Fat
International Yoga Day is celebrated on June 21 around the world. This day celebrates yoga, an ancient Indian practice that can boost overall health in more ways than one. The International Day of Yoga 2025 marks the 11th edition of this global celebration. Prime Minister Narendra Modi announced the theme for International Yoga Day during his 'Mann Ki Baat' address on March 30, 2025 which is "Yoga for One Earth, One Health." Yoga is a holistic practice that can promote overall health and well-being, including helping to reduce belly fat. Here, we have some of the best yoga poses that can help you target belly fat. Yoga poses to reduce belly fat 1. Boat pose This asana engages your core muscles and helps build strength in your abdomen. Sit on the floor, lean back slightly, lift your legs, and hold the position. 2. Plank pose A strong core is essential for reducing belly fat. Start in a push-up position, keeping your body straight from head to heels. Hold for 30 seconds to a minute. 3. Cobra pose Also known as Bhujangasana, the cobra pose strengthens the spine and helps stimulate digestive organs. Lie on your stomach, place your hands under your shoulders, and lift your chest off the ground. 4. Bridge pose This pose is excellent for engaging the core and glutes. Lie on your back, bend your knees, and lift your hips while keeping your shoulders and feet on the ground. 5. Warrior pose This pose not only strengthens the legs and abdomen but also improves overall balance and stability. Stand with legs wide apart, turn one foot out, and bend your front knee while stretching your arms out. Incorporating these poses into your regular practice, combined with a healthy diet and lifestyle, can contribute to reducing belly fat over time. Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.